Europe
Imaris 9.5: Insightful Rendering and Native Distance Measurements
Companies from across the globe share updates to their businesses and pipelines.
Although Boston and San Francisco are the biggest biotech clusters in the United States, Europe boasts its own set of hot spots for biopharma development.
The approval was based on a New Drug Application (NDA) submitted under the 505(b)(2) filing pathway.
Novartis said it will work diligently with the FDA to resolve the partial clinical hold and resume the study.
Leading manufacturer of therapeutic proteins implements Genedata Bioprocess to streamline development and manufacture of biopharmaceuticals
Demand for biological manufacturing is growing faster than capacity growth, and Emil Ciurczak forewarns the need for tighter quality controls in biosimilars production.
Large-scale public-private research initiative designed to provide new insights into the mechanisms of response and non-response to treatment within and across seven different immune-mediated diseases
BioVersys AG announced, US$ 3.94 million in non-dilutive funding from CARB-X, with the possibility of US$ 4.98 million more if certain project milestones are met.
Sense Biodetection Limited raises £12.3m to progress instrument-free molecular diagnostics
PRESS RELEASES